Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model-Reference-Cited by-同舟云学术

Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model

Published:2015-05-26 Issue:2 Volume:42 Page:254-262
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Bae Joonho¹,Park Jin Woo²

Affiliation:

1. Amorepacific Corporation R&D Center, Yongin-si, Gyeonggi-do, Republic of Korea and

2. College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam, Republic of Korea

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.3109/03639045.2015.1044906

Reference40 articles.

1. Rheumatoid arthritis

2. 3-Carboxy-5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide, new prodrug for the antiarthritic agent 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide

3. Leflunomide in the treatment of rheumatoid arthritis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent innovations in topical delivery for management of rheumatoid arthritis: A focus on combination drug delivery;Drug Discovery Today;2024-08

2. Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis;Carbohydrate Polymers;2024-03

3. Fabrication of Topical Pluronic Lecithin Organogel Containing Immunomodulatory Drug for Site-Specific Drug Delivery;Indian Journal of Pharmaceutical Education and Research;2024-02-23

4. The etiology, pathogenesis, treatment, and development of transdermal drug delivery systems for rheumatoid arthritis;RSC Pharmaceutics;2024

5. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management;Drug Delivery;2022-05-26